Clinical trial
Etanercept (Enbrel) to Treat Pain and Swelling After Third Molar Extraction
NCT00006070 · National Institute of Dental and Craniofacial Research (NIDCR), NIH · Completed
Key facts
| NCT number | NCT00006070 |
|---|---|
| Title | Etanercept (Enbrel) to Treat Pain and Swelling After Third Molar Extraction |
| Official title | Safety and Efficacy of a TNF Receptor Fusion Protein for Injury-Induced Inflammation and Sequelae |
| Lead sponsor | National Institute of Dental and Craniofacial Research (NIDCR), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Healthy, Inflammation |
| Intervention type | Drug |
| Interventions | etanercept (Enbrel) |
| Enrollment | 86 |
| Start date | Jul 1, 2000 |
| Completion | May 1, 2004 |
| First posted | Jul 19, 2000 |
| Last update posted | Mar 4, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: